U.S. Semiconductors Stock News

NasdaqGM:GCT
NasdaqGM:GCTRetail Distributors

GigaCloud Awards Spotlight Growth Story Despite Recent Share Price Volatility

GigaCloud Technology, ticker NasdaqGM:GCT, has been included on TIME's World’s Growth Leaders 2026 list. The company also received multiple Gold Stevie Awards at the 2026 American Business Awards for ecommerce, company growth, and innovation. For investors tracking NasdaqGM:GCT, this recognition comes as the stock trades around $32.41, with the share price up 74.3% over the past year and showing very large gains over three years. At the same time, the stock is down 15.5% over the past week,...
NYSE:DGX
NYSE:DGXHealthcare

Assessing Quest Diagnostics (DGX) Valuation As Shares Trade On An 11.44% Year To Date Return

Why Quest Diagnostics Stock Is On Investors’ Radar Quest Diagnostics (DGX) is drawing attention after its recent trading performance, with the stock near US$193 and multi year total returns that stand out against its long operating history in diagnostic testing services. See our latest analysis for Quest Diagnostics. The current share price of US$193.67 sits alongside an 11.44% year-to-date share price return and a 67.50% five-year total shareholder return, suggesting long-term holders have...
NasdaqGS:GTM
NasdaqGS:GTMInteractive Media and Services

Assessing ZoomInfo Technologies (GTM) Valuation After Its Recent Share Price Slide

Why ZoomInfo Technologies (GTM) Is Back on Investors’ Radar ZoomInfo Technologies (GTM) has drawn attention after a steep share price decline, with the stock down 52% over the past month and 53% over the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for ZoomInfo Technologies. At a share price of US$3.12, ZoomInfo’s momentum has clearly faded, with the stock’s share price return falling 52.2% over 30 days and its 1 year total shareholder return declining...
NYSE:LBRT
NYSE:LBRTEnergy Services

A Look At Liberty Energy (LBRT) Valuation After Strong Q1 2026 Beat And Tight Premium Fleet Demand

Liberty Energy (LBRT) just posted first quarter 2026 results that topped Wall Street forecasts on both revenue and earnings, with management highlighting strong demand for its premium fleet and StimCommander that currently exceeds available deployment capacity. See our latest analysis for Liberty Energy. Despite the strong Q1 beat and tight premium fleet capacity, Liberty Energy’s share price has cooled in the past month, with an 8.5% decline over 30 days. However, the 64.5% year to date...
NYSE:AFL
NYSE:AFLInsurance

The Bull Case For Aflac (AFL) Could Change Following Q1 Earnings Beat And $1 Billion Payouts

Aflac recently reported strong first-quarter 2026 results, highlighting solid revenue, sustained profitability, and returning about US$1.00 billion to shareholders through dividends and share repurchases. Alongside this, Aflac’s recognition of Dr. Heather Bittner Fagan as an Aflac Check for Cancer Champion underscores the company’s emphasis on cancer prevention and screening, reinforcing the relevance of its supplemental health products. Next, we’ll examine how Aflac’s robust earnings and...
NYSEAM:CET
NYSEAM:CETCapital Markets

Central Securities (CET) Valuation Check After Recent Share Price Softness And Discounted P/E Ratio

Central Securities (CET) offers investors a closed end fund focused on US securities. Shares recently closed at US$52.70 and the fund has a market value around US$1.6b, inviting closer attention to its valuation profile. See our latest analysis for Central Securities. Recent trading has been slightly softer, with the share price down over the past month but still showing a positive 90 day share price return of 2.33% and a 1 year total shareholder return of 19.12%. This points to momentum that...
NasdaqGS:SBCF
NasdaqGS:SBCFBanks

Assessing Seacoast Banking Corporation of Florida (SBCF) Valuation After Recent Share Weakness And Acquisition Activity

Recent share performance and current context Without a specific event driving headlines, Seacoast Banking Corporation of Florida (SBCF) still offers investors a mix of recent share performance data and fundamentals that can help frame expectations and portfolio decisions. See our latest analysis for Seacoast Banking Corporation of Florida. Recent trading has been softer, with the share price down 3% over the past day and about 7% year to date, while the 1 year total shareholder return of 17%...
NasdaqGS:PAYX
NasdaqGS:PAYXProfessional Services

The Bull Case For Paychex (PAYX) Could Change Following Strength In Small-Business Hiring And Earnings Beat Hopes

In recent days, Paychex reported that its Small Business Jobs Index rose for a third straight month in May 2026, reaching its highest level this year and signaling improving job growth among U.S. firms with fewer than 50 employees. At the same time, the company’s track record of topping earnings estimates and a currently positive Earnings ESP have reinforced investor attention on how labor-market strength could support demand for its payroll and HR services. Next, we’ll examine how this...
NYSE:NVT
NYSE:NVTElectrical

Nvidia Alliance Puts nVent At Center Of AI Data Center Buildout

Nvidia, Siemens, and nVent Electric (NYSE:NVT) released a blueprint for 100-megawatt AI data centers, highlighting nVent’s liquid cooling and plumbing hardware as key infrastructure. The design targets next generation AI facilities that require high power density and advanced thermal management. This partnership positions nVent directly inside the core buildout plans for large scale AI computing projects. For investors who have watched NYSE:NVT, the story has recently centered on buybacks,...
NYSEAM:KULR
NYSEAM:KULRElectrical

Defense Drone Battery Prototype Deal Could Be A Game Changer For KULR Technology Group (KULR)

KULR Technology Group recently announced it entered into a prototype development and fabrication agreement with a U.S.-based defense drone manufacturer to design, test, and qualify lithium-ion battery packs for unmanned aerial vehicles and handheld controllers, while also advancing next-generation drone battery pack integration using Factorial Inc.’s solid-state and lithium-metal cells. Together, these collaborations deepen KULR’s role in mission-critical unmanned systems by pairing its KULR...
NYSE:RKT
NYSE:RKTDiversified Financial

Is It Time To Reassess Rocket Companies (RKT) After Recent Share Price Pullback?

If you are wondering whether Rocket Companies stock is priced attractively today, the starting point is understanding how its current share price lines up against several valuation checks. The stock closed at US$12.94, with the share price down 9.3% over the past week, 7.6% over the past month and 34.9% year to date, while still showing a 3.8% gain over the last year and a 59.7% gain over three years, but down 32.3% over five years. Recent coverage around Rocket Companies has focused on its...
NasdaqGS:BKNG
NasdaqGS:BKNGHospitality

Is It Time To Reassess Booking Holdings (BKNG) After This Year’s Share Price Slide

If you are wondering whether Booking Holdings at around US$164.78 is attractively priced or not, the key is understanding what the current share price actually reflects about its long term prospects. The stock is down 2.1% over the past week, 0.5% over the past month, 22.6% year to date and 25.3% over the last year, even though the 3 year and 5 year returns sit at 58.7% and 81.3% respectively. These moves have come as investors reassess many travel related stocks, with attention on how...
NYSE:KVYO
NYSE:KVYOSoftware

Why Klaviyo (KVYO) Is Up 10.4% After Raising 2026 Guidance And Launching A $500 Million Buyback

Klaviyo recently reported strong Q1 2026 results, with 28% year-over-year revenue growth, its best operating margin since listing, a larger customer base of more than 196,000 accounts, and a newly authorized US$500.00 million share repurchase program. The company also raised its full-year 2026 revenue guidance while emphasizing deeper AI integration across its platform, underscoring management’s focus on AI-enabled expansion and capital returns even as it prepares for a CFO transition later...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Is It Too Late To Consider Flywire (FLYW) After A 46% One Year Gain?

Wondering if Flywire's current share price around US$14.61 still leaves room for value, or if most of the upside is already priced in. The stock is down 7.6% over the past week but up 2.7% over the last month, 5.1% year to date, and 46.1% over the past year, which can change how you think about both its potential and its risk. These moves come after a period where investors have been reassessing high growth payment and financial technology stocks. There has been attention on business models...
NasdaqGS:ANAB
NasdaqGS:ANABBiotechs

AnaptysBio Shifts Fiscal Year-End As Volatile Stock Eyes Growth Forecasts

AnaptysBio (NasdaqGS:ANAB) has approved a change in its fiscal year-end from December 31 to June 30. The new fiscal year-end is expected to affect the timing of future financial reports and corporate disclosures. The decision reflects an adjustment to the company’s reporting calendar and financial planning framework. AnaptysBio, trading at $51.24, has recorded very large share price gains over the past year, with the stock up 261.4% over that period and 220.2% over five years. The...
NYSE:SF
NYSE:SFCapital Markets

Is Stifel Financial (SF) Offering Value After Recent Pullback And Capital Markets Headlines

Wondering if Stifel Financial, at a recent US$69.37 share price, is offering value or just noise? This article breaks down what that price could mean for you. The stock is down 1.8% over the past week and 9.2% over the past month, even though the 1 year return sits at 13.4% and the 3 year and 5 year returns are 83.9% and 76.5% respectively. Recent headlines around capital markets activity and the broader financial sector have kept investor attention on firms such as Stifel Financial. This...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Veracyte (VCYT) Is Up 9.4% After New Phase III Data Validates Prosigna Chemotherapy-Guidance Role – Has The Bull Case Changed?

Veracyte has recently reported strong Phase III clinical data for its Prosigna Breast and Decipher Prostate genomic tests at ASCO 2026 and confirmed the upcoming U.S. commercial launch of Prosigna on June 8, 2026 for early-stage hormone-receptor positive breast cancer patients. The new evidence suggests these tests can help oncologists tailor chemotherapy use more precisely, potentially sparing many high-risk breast and prostate cancer patients from unnecessary treatment and its long-term...
NYSE:RTX
NYSE:RTXAerospace & Defense

Is RTX (RTX) Still Fairly Priced After Recent Share Price Pullback?

If you are wondering whether RTX at around US$172.55 a share offers fair value or is starting to look stretched, the valuation picture is the key place to focus. RTX's share price has pulled back slightly in the short term, declining 2.3% over the last week and 0.2% over the last month, and is also down 7.9% year to date, even though it is still up 26.5% over 1 year, 86.5% over 3 years and 116.8% over 5 years. These mixed returns arrive as investors continue to weigh broader defense and...
NYSE:YUM
NYSE:YUMHospitality

Will Yum! Brands’ (YUM) COO Transition and New Roles Redefine Its Culture and Franchise Strategy?

Yum! Brands has announced that longtime Chief Operating Officer and Chief People & Culture Officer Tracy Skeans will retire, with her transitioning from her current roles on November 1, 2026, into a Senior Advisor position until March 1, 2028. Her planned retirement marks the departure of a key architect of Yum!’s franchising model and culture, prompting a multi‑year leadership transition as the company recruits a new Chief People & Culture Officer and a new Chief Scale Officer. With this...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

A Look At Nuvation Bio (NUVB) Valuation After New IBTROZI Outcomes And Regulatory Progress

Nuvation Bio (NUVB) is back in focus after reporting new patient-reported outcomes from its pivotal TRUST-II study of IBTROZI in advanced ROS1+ non small cell lung cancer, alongside fresh regulatory milestones. See our latest analysis for Nuvation Bio. The recent TRUST-II data and regulatory updates arrive after a mixed share price pattern, with a 30 day share price return of 7.03% and a year to date share price decline of 44.99%, while the 1 year total shareholder return is 92.65% and the 3...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Cognizant Deepens AI And Security Ties As Valuation Lags Targets

Cognizant Technology Solutions (NasdaqGS:CTSH) expanded its AI collaboration with Snowflake to deploy AI-powered intelligent agents at scale across industries. The companies aim to help enterprises adopt AI more quickly, with a focus on AI-driven business workflows and measurable operational outcomes. Cognizant also broadened its alliance with CrowdStrike to address security and governance needs tied to large-scale AI deployments. Cognizant sits at the intersection of IT services, cloud...
NasdaqCM:LPTH
NasdaqCM:LPTHElectronic

LightPath Raises US$50m Equity For Growth While Dilution Weighs On Holders

LightPath Technologies (NasdaqCM:LPTH) has completed a follow-on equity offering via a registered direct deal. The company raised gross proceeds of US$50 million. Management plans to use the new capital for working capital, investments, acquisitions, and other corporate purposes. LightPath Technologies focuses on photonics solutions, supplying optical components and related products into areas where demand for high precision optics has been growing across multiple applications. This fresh...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

Is XP (XP) Looking Attractive After Recent Share Price Pullback?

If you are wondering whether XP at around US$15.60 is starting to look like a bargain or still carries too much risk, the recent share performance gives you some important clues. The stock has fallen about 9% over the past week, around 15.7% over the past month, and is down 19.5% over the past year. This may change how investors think about both its potential and its risks. Recent coverage of XP has focused on how the stock has pulled back over different timeframes and what that says about...
NasdaqGM:BLBD
NasdaqGM:BLBDMachinery

Is It Too Late To Consider Blue Bird (BLBD) After Its 85% One Year Surge?

Some investors may be wondering whether Blue Bird's share price still offers value after a strong run, or if most of the opportunity has already been priced in. The stock last closed at US$72.43, with returns of 2.2% over 7 days, 15.2% over 30 days, 54.9% year to date and 85.6% over the past year. Recent coverage has focused on how this long term share price performance has sharpened the market's focus on what Blue Bird might be worth compared with its current price. Investors are watching...